Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SCIO Scios Inc. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1428)	4/20/2002 12:42:27 PM
From: quidditch	Read Replies (2) \| Respond to of 1477

Thanks, Rick (I owe you an acknowledgement on a TLRK post): Maybe SCIO management IS doing things right. In the cc, the CSO or VP Medicine indicated that other molecules targeting p38 were in pre-clinical testing backing up S-469 lead candidate. If I had been a long-standing follower of BT (I gravitated to following Peter, Rick, rkrw, Miljenko and others only in Feb 2001, or so) with a position in SCIO, I would probably have bailed at continuous disappointments in Calif Biotech and never looked back. Thus, there is something to be said for being late to the party--although the party seems a bit dull, depressed and played out recently. And there would be no party at SI at all but for those mentioned above (+ Metcalf, Harold, BT Jim, Stefaan, tuck, Vector, nigel, ij (keen financial eye) and others I'm clumsy enough to have left out). Thank you ALL. quid